UC Davis Health Ventures is the university health system’s innovation and commercialization arm within the Innovation and Economic Development Office. It helps turn research in therapeutics, digital health, diagnostics and medical devices into products and companies through intellectual-property development, industry partnerships and a venture studio. Its Investing in the Future of Medicine program supports research translation, startup incubation and investments in aligned companies.
Founded
—
Type
Venture capital
Funds1
Investing in the Future of Medicine Fund$25M
A $25 million university investment initiative launched alongside the Health Venture Studio to fund research translation, incubate UC Davis startups and invest in aligned external companies. This is a university funding program; the announcement is its launch, and does not identify an external limited-partner final close.
Team
Operations and support
Andrew BrownDirector, Strategic Product Portfolios
Delix Therapeutics